Figure 9

Association of RiskScore, infiltrated immune cell and immunotherapy response via TCGA-ESCC datasets. (A,B) Differences in immune cell infiltration and immune checkpoint gene expression between two subgroups. *P < 0.05; **P < 0.01; ***P < 0.001. (C) Differences in immunotherapy efficacy between two risk subgroups in TCGA-ESCC cohorts. (D) Immunotherapy response between high and low-RiskScore groups in the IMvigor210 datasets.